Role of epigenetic aberrations in the development and progression of human hepatocellular carcinoma

被引:124
|
作者
Pogribny, Igor P. [1 ]
Rusyn, Ivan [2 ]
机构
[1] NCTR, Div Biochem Toxicol, Jefferson, AR 72079 USA
[2] Univ N Carolina, Dept Environm Sci & Engn, Chapel Hill, NC 27599 USA
关键词
Hepatocellular carcinoma; DNA methylation; Histone modifications; MicroRNAs; PERICENTROMERIC SATELLITE REGIONS; ABERRANT PROMOTER METHYLATION; GENOME-WIDE HYPOMETHYLATION; TUMOR-SUPPRESSOR GENES; DNA METHYLATION; MESSENGER-RNA; LIVER-CANCER; HEPATITIS-B; CPG-ISLANDS; CLINICOPATHOLOGICAL SIGNIFICANCE;
D O I
10.1016/j.canlet.2012.01.038
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Hepatocellular carcinoma (HCC) is one of the most lethal and prevalent cancers in humans. The molecular mechanisms leading to the development of HCC are extremely complicated and consist of prominent genetic, genomic, and epigenetic alterations. This review summarizes the current knowledge of the role of epigenetic aberrations, including changes in DNA methylation, histone modifications, and expression of microRNAs in the pathogenesis of HCC. It also emphasizes that identification of the underlying epigenetic alterations that drive cell transformation and promote development and progression of HCC is crucially important for understanding mechanisms of hepatocarcinogenesis, its detection, therapeutic intervention, and prevention. Published by Elsevier Ireland Ltd.
引用
收藏
页码:223 / 230
页数:8
相关论文
共 50 条
  • [21] The role of regulatory B cells during the progression of human hepatocellular carcinoma
    Shao, Yan
    Li, Chang Xian
    Ma, Yuen Yuen
    Liu, Xiao Bing
    Chu, Chi Yuen
    Ling, Chang Chun
    Yeung, Wai Ho
    Lee, Kin Wah
    Fan, Sheung Tat
    Lo, Chung Mau
    Man, Kwan
    JOURNAL OF IMMUNOLOGY, 2012, 188
  • [22] The role of lipid peroxidation during the progression of human hepatocellular carcinoma (HCC)
    Yin, Huiyong
    FREE RADICAL BIOLOGY AND MEDICINE, 2018, 124 : 563 - 564
  • [23] Chromatin remodeler HELLS is an epigenetic driver for hepatocellular carcinoma progression
    Law, Cheuk-Ting
    Wei, Larry L.
    Tsang, Felice H. C.
    Xu, Iris M. J.
    Lai, Robin K. H.
    Ho, Daniel W. H.
    Lee, Joyce M. F.
    Wong, Carmen C. L.
    Ng, Irene O. L.
    Wong, Jack C. M.
    CANCER RESEARCH, 2017, 77
  • [24] New insights on the role of epigenetic alterations in hepatocellular carcinoma
    Frau, Maddalena
    Feo, Claudio F.
    Feo, Francesco
    Pascale, Rosa M.
    JOURNAL OF HEPATOCELLULAR CARCINOMA, 2014, 1 : 65 - 83
  • [25] The Role of miRNAs, circRNAs and Their Interactions in Development and Progression of Hepatocellular Carcinoma: An Insilico Approach
    Ishaq, Yasmeen
    Ikram, Aqsa
    Alzahrani, Badr
    Khurshid, Sana
    GENES, 2023, 14 (01)
  • [26] An Insight Into the Role of Alpha-Fetoprotein (AFP) in the Development and Progression of Hepatocellular Carcinoma
    Samban, Swathy S.
    Hari, Aparna
    Nair, Bhagyalakshmi
    Kumar, Ayana. R.
    Meyer, Benjamin S.
    Valsan, Arun
    Vijayakurup, Vinod
    Nath, Lekshmi R.
    MOLECULAR BIOTECHNOLOGY, 2024, 66 (10) : 2697 - 2709
  • [27] The role of lncRNA ANRIL in the progression of hepatocellular carcinoma
    Han, Weijie
    Wang, Qiuhong
    Zheng, Liansheng
    Hong, Hong
    Yan, Boshi
    Ma, Yongqiang
    Li, Xiaolong
    Zhou, Dinghua
    JOURNAL OF PHARMACY AND PHARMACOLOGY, 2021, 73 (08) : 1033 - 1038
  • [28] The role of psychosocial factors in the progression of hepatocellular carcinoma
    Steel, J
    Carney, M
    Carr, BI
    Baum, A
    MEDICAL HYPOTHESES, 2004, 62 (01) : 86 - 94
  • [29] ROLE OF TGFβ2 IN HEPATOCELLULAR CARCINOMA PROGRESSION
    Makarova, M. V.
    Donner, N. E.
    Fleishman, D. I.
    Morozova, O. V.
    Lazarevich, N. L.
    JOURNAL OF HEPATOLOGY, 2009, 50 : S196 - S196
  • [30] Development of novel epigenetic inhibitors for the treatment of hepatocellular carcinoma
    Barcena-Varela, M.
    Oyarzabal, J.
    Banales, J. M.
    Prieto, J.
    Alvarez-Asiain, L.
    Prosper, F.
    Berasain, C.
    Avila, M. A.
    Fernandez-Barrena, M. G.
    JOURNAL OF HEPATOLOGY, 2017, 66 (01) : S76 - S77